Claimbdaedd178d9920e4ff8500e0d0550553862b3f5fee313d85da3b9727c18639d1·My Arguments

Claim

SSRIs can cause treatment-emergent suicidal ideation in a small subset of patients who had no suicidal thoughts prior to treatment, most likely via an activation syndrome mechanism rather than a direct pharmacological effect on suicidal intent.

Evidence (2)

SSRIs, Childhood and Adolescent Depression, and Suicidality Following the FDA's 2004 Black Box Warning: A Systematized Literature Review (Kaur & Memon, 2025)
2025 systematized review finding small but measurable increase in suicidal risk with SSRI use, especially early in treatment; combination therapy (SSRI + CBT) yields better outcomes.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12854806/
Suicidality during treatment with serotonin and norepinephrine reuptake inhibitors (Da Fonseca Pinto et al., 2024)
Concludes antidepressants overall decrease suicide attempt risk, but notes increasing suicidality may relate to side effects like anxiety, agitation, and irritability, and to poor treatment response.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11862216/

Dialectical view

Public arguments concluding to this claim, and structural counter-arguments that contest it.

Arguments for (1)

Arguments against (0)

No structural counter-arguments are on file.

Browse all counter-arguments to this claim

Embed this claim

<iframe
  src="https://www.isonomia.app/embed/claim/bdaedd178d9920e4ff8500e0d0550553862b3f5fee313d85da3b9727c18639d1"
  width="600"
  height="280"
  frameborder="0"
  style="border: 1px solid #e5e7eb; border-radius: 8px;"
  title="Isonomia Claim"
  loading="lazy"
></iframe>

Copy and paste into any website or forum that supports HTML.

Respond to this claim on Isonomia

Build or challenge arguments with structured reasoning in the Digital Agora.

View full deliberationJoin & respond